Bicarbonate

Bicarbonate

SCHEMBL1718183

CC[N+]1(COC)CCCC1.CC[N+]1(COC)CCCC1.O=C([O-])[O-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1718187 0.94 CHRM2 (0.35) CHRM2CHRM4CHRM5CYP2D6CHRM1
Acetic Acid SCHEMBL1716931 0.94 CHRM2 (0.32) CHRM2CHRM4CHRM5CYP2D6CHRM1
Trifluoroacetic Acid SCHEMBL907643 0.89 CHRM2 (0.33) CHRM2CHRM4CHRM5CYP2D6CHRM1
SCHEMBL1717537 0.88 CHRM2 (0.32) CHRM2CHRM4CHRM5CYP2D6CHRM1
SCHEMBL1718893 0.87 KDM4E (0.33)
Hydrochloric Acid SCHEMBL907634 0.85 KDM4E (0.32)
Fluoride Ion SCHEMBL907624 0.85 KDM4E (0.32)
SCHEMBL3314119 0.85 KDM4E (0.37) CHRM2CHRM4CHRM5CYP2D6CHRM1
Water SCHEMBL1717648 0.85 KDM4E (0.32)
SCHEMBL3447164 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8747690-B2 Quaternary ammonium salt and composition, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2014-06-10 US disclosed
US-8366956-B2 Quaternary ammonium salt and composition, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2013-02-05 US disclosed
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE STELLA CHEMIFA CORPORATION (JP) 2013-01-03 US disclosed
EP-1642894-B1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL CO LTD (JP) 2012-01-18 EP disclosed
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device STELLA CHEMIFA CORPORATION (JP) 2011-05-26 US disclosed
US-7834197-B2 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2010-11-16 US disclosed
EP-2172463-A1 Quaternary ammonium salt, electrolytic solution and electrochemical device Otsuka Chemical Co., Ltd. (JP) 2010-04-07 EP disclosed
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1642894-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device DNMT3A, AFF4, AFF2 CHRM2 428/4885CHRM4 232/4885CHRM5 672/4885
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device DNMT3A, NHERF1, SLC9A1 CHRM2 815/4885CHRM4 777/4885CHRM5 926/4885
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE DNMT3A, AFF4, AFF2 CHRM2 428/4885CHRM4 232/4885CHRM5 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.